241. Hypertyrosinemia type I
14 clinical trials,   7 drugs   (DrugBank: 1 drug),   1 drug target gene,   5 drug target pathways

Searched query = "Hypertyrosinemia type I", "Tyrosinemia type I", "Tyrosinemia I", "Hereditary tyrosinemia, Type I", "Fumarylacetoacetate hydrolase deficiency", "FAH deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00004443
(ClinicalTrials.gov)
October 199818/10/1999Study of NTBC for Tyrosinemia ITyrosinemia IDrug: NTBCUniversity of WashingtonNULLCompletedN/A17 YearsBoth20N/AUnited States;Canada
2NCT00004333
(ClinicalTrials.gov)
November 199418/10/1999Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type ITyrosinemia, Type IDrug: NTBCNational Center for Research Resources (NCRR)University of MichiganCompletedN/AN/ABothPhase 2NULL